We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Two United Nations special envoys have urged India to make "enlightened
decisions" while making amendments to the Patents Act, saying such a step
was needed to ensure that the world is not deprived of cheap medicines, including
drugs used to treat AIDS.
Epimmune, a developer of vaccines for cancer and infectious diseases, and privately
held Immuno-Designed Molecules S.A., agreed to merge in an all-stock transaction.
International agency Oxfam America is deeply concerned about U.S. pressure exerted
on Guatemala to repeal a law to improve public health as a condition for approving
CAFTA.
According to Al-Sabaah newspaper, the Iraqi Ministry of Health announced that
it is willing to soon impose a new system to price pharmaceuticals at the public
pharmacies in the country in cooperation with the Pharmacists Association.
Toray Industries, Japan Tobacco and Torii Pharmaceutical
jointly announced that they have entered into a contract for TRK-820, a selective
kappa opioid receptor agonist.
Israeli lawmakers and officials continue to debate mechanisms for
regulating the export of R&D expertise and manufacturing technologies developed
in the country under government sponsorship.
The Hungarian government's harsh cost-cutting policy and the country's
membership in the European Union have prompted the local industry to focus on
the export market in recent years.
Rising competition in the local drug sector, largely prompted by
price pressures and the onset of tighter regulation, is increasingly obliging
Indian firms to consolidate their operations.
Speaking about press coverage of the Institute's technology appraisal on the
use of donepezil, rivastigmine, galantamine and memantine for the treatment
of Alzheimer's disease, NICE Chief Executive Andrew Dillon stated: "The
Institute would like to make it clear that contrary to recent press reports
it has not been asked or told by Ministers to reverse its advisory committee's
provisional recommendations on the use of these drugs.